Literature DB >> 27110490

Pigmentation of the Tongue with Lapatinib Treatment in a Patient with Advanced Breast Cancer: A Case Report.

Matthew D Bloom1, Joseph M Gibney1, Coy D Heldermon1.   

Abstract

Entities:  

Keywords:  EGFR; lapatinib; pigmentation; tongue

Year:  2016        PMID： 27110490      PMCID： PMC4835819          DOI： 10.1016/j.ctrc.2016.02.006

Source DB:  PubMed          Journal:  Cancer Treat Commun        ISSN： 2213-0896


× No keyword cloud information.
  19 in total

Review 1.  Prevention and management of major side effects of targeted agents in breast cancer.

Authors:  Otto Metzger Filho; Kamal S Saini; Hatem A Azim; Ahmad Awada
Journal:  Crit Rev Oncol Hematol       Date:  2011-03-15       Impact factor: 6.312

2.  Mucosal hyperpigmentation from prophylactic minocycline for EGFR inhibitor.

Authors:  K Imafuku; K Natsuga; S Aoyagi; H Shimizu
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-01-28       Impact factor: 6.166

Review 3.  Dermatologic side effects associated with the epidermal growth factor receptor inhibitors.

Authors:  Anna Liza C Agero; Stephen W Dusza; Cristiane Benvenuto-Andrade; Klaus J Busam; Patricia Myskowski; Allan C Halpern
Journal:  J Am Acad Dermatol       Date:  2006-10       Impact factor: 11.527

4.  Mucosal pigmentation caused by imatinib: report of three cases.

Authors:  Chia-Cheng Li; Salman M Malik; Bart F Blaeser; Walid J Dehni; Sadru P Kabani; Niamh Boyle; Mary Toner; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-12-31

5.  Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.

Authors:  Kimberly L Blackwell; Harold J Burstein; Anna Maria Storniolo; Hope S Rugo; George Sledge; Gursel Aktan; Catherine Ellis; Allison Florance; Svetislava Vukelja; Joachim Bischoff; José Baselga; Joyce O'Shaughnessy
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

6.  An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?

Authors:  Biju Vasudevan
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

7.  Chemotherapy-associated tongue hyperpigmentation and blue lunula.

Authors:  Kathleen M Casamiquela; Philip R Cohen
Journal:  J Drugs Dermatol       Date:  2013-02       Impact factor: 2.114

Review 8.  Analysis of dermatologic events in patients with cancer treated with lapatinib.

Authors:  M E Lacouture; S M Laabs; M Koehler; R W Sweetman; A J Preston; A Di Leo; H L Gomez; V M Salazar; J A Byrne; K M Koch; K L Blackwell
Journal:  Breast Cancer Res Treat       Date:  2008-07-04       Impact factor: 4.872

9.  Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.

Authors:  Guillermo Villalón; Jose M Martín; Maria I Pinazo; Luis Calduch; Vicente Alonso; Esperanza Jordá
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

10.  Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: analysis from the NeoALTTO trial.

Authors:  Hatem A Azim; Dominique Agbor-Tarh; Ian Bradbury; Phuong Dinh; Jose Baselga; Serena Di Cosimo; James G Greger; Ian Smith; Christian Jackisch; Sung-Bae Kim; Bahriye Aktas; Chiun-Sheng Huang; Peter Vuylsteke; Ruey Kuen Hsieh; Lydia Dreosti; Holger Eidtmann; Martine Piccart; Evandro de Azambuja
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544
View more
  1 in total

Review 1.  Pigmented Fungiform Papillae (PFP) of the Tongue: A Systematic Review of Current Aetiopathogenesis and Pathophysiology.

Authors:  Meircurius Dwi Condro Surboyo; Lakshman Samaranayake; Arvind Babu Rajendra Santosh; Nurina Febriyanti Ayuningtyas; Sisca Meida Wati; Retno Pudji Rahayu; Francisco Urbina; Winni Langgeng Kuntari; Sesaria Junita Mega Rahma Syahnia; Karlina Puspasari; Adiastuti Endah Parmadiati; Diah Savitri Ernawati
Journal:  Pathophysiology       Date:  2022-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.